Nanozyme‐based tumor catalytic therapy has attracted widespread attention in recent years, but its therapeutic outcome is drastically diminished by species of nanozyme, concentration of substrate, pH value, and reaction temperature, etc. Herein, a novel Cu‐doped polypyrrole nanozyme (CuP) with trienzyme‐like activities, including catalase (CAT), glutathione peroxidase (GPx), and peroxidase (POD), is first proposed by a straightforward one‐step procedure, which can specifically promote O
2
and ·OH elevation but glutathione (GSH) reduction in tumor microenvironment (TME), causing irreversible oxidative stress damage to tumor cells and reversing the redox balance. The PEGylated CuP nanozyme (CuPP) has been demonstrated to efficiently reverse immunosuppressive TME by overcoming tumor hypoxia and re‐educating macrophage from pro‐tumoral M2 to anti‐tumoral M1 phenotype. More importantly, CuPP exhibits hyperthermia‐enhanced enzyme‐mimic catalytic and immunoregulatory activities, which results in intense immune responses and almost complete tumor inhibition by further combining with
α
PD‐L1. This work opens intriguing perspectives not only in enzyme‐catalytic nanomedicine but also in macrophage‐based tumor immunotherapy.
This paper introduces a methodology for building synthetic electric grid data sets that represent fictitious, yet realistic, combined transmission and distribution (T&D) systems. Such data sets have important applications, such as in the study of the wide-area interactions of distributed energy resources, in the validation of advanced control schemes, and in network resilience to severe events. The data sets created here are geographically located on an actual North American footprint, with the enduser load information estimated from land parcel data. The grid created to serve these fictional but realistic loads is built starting with low-voltage and medium-voltage distribution systems in full detail, connected to distribution and transmission substations. Bulk generation is added, and a high-voltage transmission grid is created. This paper explains the overall process and challenges addressed in making the combined case. An example test case, syn-austin-TDgrid-v03, is shown for a 307,236-customer case located in central Texas, with 140 substations, 448 feeders, and electric line data at voltages ranging from 120 V to 230 kV. Such new combined test cases help to promote high quality in the research on large-scale systems, particularly since much actual power system data are subject to data confidentiality. The highly detailed, combined T&D data set can also facilitate the modeling and analysis of coupled infrastructures.
BackgroundIt has been well-established, both by population genetics theory and direct observation in many organisms, that increased genetic diversity provides a survival advantage. However, given the limitations of both sample size and genome-wide metrics, this hypothesis has not been comprehensively tested in human populations. Moreover, the presence of numerous segregating small effect alleles that influence traits that directly impact health directly raises the question as to whether global measures of genomic variation are themselves associated with human health and disease.ResultsWe performed a meta-analysis of 17 cohorts followed prospectively, with a combined sample size of 46,716 individuals, including a total of 15,234 deaths. We find a significant association between increased heterozygosity and survival (P = 0.03). We estimate that within a single population, every standard deviation of heterozygosity an individual has over the mean decreases that person’s risk of death by 1.57%.ConclusionsThis effect was consistent between European and African ancestry cohorts, men and women, and major causes of death (cancer and cardiovascular disease), demonstrating the broad positive impact of genomic diversity on human survival.Electronic supplementary materialThe online version of this article (doi:10.1186/s12863-014-0159-7) contains supplementary material, which is available to authorized users.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.